SIP
NVAX icon

Stoneridge Investment Partners’s Novavax NVAX Stock Holding History

Stoneridge Investment Partners’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-10,485
Closed -$1.08M – 313
2016
Q1 		$1.08M Sell
10,485
-1,083
-9% -$116K 0.16% 154
2015
Q4 		$1.94M Buy
11,568
+186
+2% +$28.6K 0.26% 115
2015
Q3 		$1.61M Sell
11,382
-2,728
-19% -$612K 0.23% 124
2015
Q2 		$3.14M Sell
14,110
-22,148
-61% -$3.89M 0.39% 74
2015
Q1 		$6M Sell
36,258
-9,169
-20% -$1.49M 0.7% 38
2014
Q4 		$5.39M Buy
45,427
+7,881
+21% +$824K 0.71% 36
2014
Q3 		$3.13M Sell
37,546
-80
-0.2% -$7.23K 0.46% 74
2014
Q2 		$3.48M Buy
37,626
+27,164
+260% +$2.39M 0.52% 63
2014
Q1 		$948K Buy
10,462
+6,528
+166% +$729K 0.18% 94
2013
Q4 		$403K Buy
3,934
+559
+17% +$39.5K 0.08% 137
2013
Q3 		$213K Buy
3,375
+605
+22% +$34.1K 0.05% 177
2013
Q2 		$114K Buy
+2,770
New +$120K 0.03% 194

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Stoneridge Investment Partners's NVAX Position: Q2 2016 in Review

Stoneridge Investment Partners sold out of Novavax (NVAX) in Q2 2016, closing a stake of 10,485 shares — an estimated $1.08M sold.

Stoneridge Investment Partners first reported a position in NVAX in Q2 2013 and held it in 12 quarters. The position peaked at $6M in Q1 2015. 186 funds tracked by Wall St. Rank hold NVAX as of Q2 2016.

  • Stoneridge Investment Partners reported no remaining Novavax position as of Q2 2016 after selling out during the quarter.
  • Stoneridge Investment Partners sold 10,485 Novavax shares in Q2 2016, an estimated $1.08M.
  • Stoneridge Investment Partners first reported a position in Novavax in Q2 2013 and held it in 12 quarters.
  • Stoneridge Investment Partners's Novavax position peaked at $6M in Q1 2015.
  • 186 funds tracked by Wall St. Rank held Novavax as of Q2 2016.

Based on Stoneridge Investment Partners's 13F filing for Q2 2016, filed 25 Jul 2016.